The Glucose Monitoring Devices Market research report includes Market segmentation and overlays shadow upon the leading market players highlighting the favourable competitive landscape and trends prevailing over the years. This study provides information about the sales and revenue during the historic and forecasted period of 2019 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the Glucose Monitoring Devices market growth.
The market size is expected to reach US$ 21,850.9 million by 2027 from US$ 12,628.3 million in 2018; it is estimated to grow at a CAGR of 6.4% during 2019–2027.
The report highlights trends prevailing in the market and factors driving its growth. The glucose monitoring devices market growth is attributed to the increasing prevalence of obesity globally and rapid technological advancements in glucose monitoring devices. However, lower diagnosis and treatment rates in emerging countries restrict the adoption of devices, thereby hindering the market growth.
Get Sample Copy of this Report at https://www.theinsightpartners.com/sample/TIPRE00004116/
Companies Profiled in this report includes:
- Hoffmann-La Roche Ltd.
- Braun Melsungen AG
- Medtronic
- Abbott
- LifeScan, Inc.
- Ascensia Diabetes Care Holdings AG
- Ypsomed AG
- Omron Corporation
- GE Healthcare
- Nipro Corporation
Leading market players and manufacturers are studied to help give a brief idea about them in the report. The challenges faced by them and the reasons they are on that position is explained to help make a well informed decision. Competitive landscape of Glucose Monitoring Devices market is given presenting detailed insights into the company profiles, developments, merges, acquisitions, economic status and best SWOT analysis.
Glucose Monitoring Devices Market: Segmental Overview
Product-Based Insights
The global glucose monitoring devices market, based on product, is segmented into glucometers, lancets, testing strips, and other glucose monitoring devices. The testing strips segment is the largest among the product subsegments in the market in 2018; it is also expected to witness growth in its demand at the fastest CAGR of 7.0% during 2019–2027.
End User-Based Insights
The global glucose monitoring devices market, based on end user, is segmented into home care and hospitals & clinics. The homecare segment held a larger share in 2018 and is expected to witness growth in its demand at a faster CAGR during 2019–2027
Reasons for buy this Report
Highlights key business priorities to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the Glucose Monitoring Devices market, thereby allowing players to develop effective long term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin commercial interest to components, type, and end-users.
About The Insight Partners:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defence, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: [email protected]
Phone: +1-646-491-9876
